Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
124.60    -1.80 (-1.42%)
Bid:
124.00
Ask:
125.00
Spread: 1.00 (0.806%)
Market Cap: £518.85m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Interim Results

30 Mar 2009 07:00

RNS Number : 6608P
James Halstead PLC
30 March 2009
Β 

ο»Ώ

30Β March 2009

JAMES HALSTEAD PLC

INTERIM RESULTS FOR THE HALF-YEAR ENDEDΒ 31 DECEMBER 2008

Key Figures

James Halstead plc, manufacturer and international distributor of commercial floor coverings reports:

Turnover increased to a record Β£86.7 million - an increase of 10.4%

Operating profit increased to a record Β£15.1 million - an increase of 19.7%

Pre-tax profit increased to a record Β£15.4 million - an increase of 17.5%

Basic earnings per ordinary 5p share increased to a record 20.8p - an increase of 19.5%

Proposed interim dividend increased to a record 7.25 p - an increase of 16%

Nil net gearing

Chairman, Mr Geoffrey Halstead, commenting said:

"We have yet again achieved record results in very challenging market conditions. Our cash generation, market penetration and productivity have all moved forward.Β Many economies at the momentΒ are in a difficult position but our conservative strategy of building our businesses solidly should allow us to weather these stormsΒ and this gives us the confidence to raise the interim dividend 16%".Β 

Enquiries:

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Telephone: 0161 767 2500

Nick Lyon -Β HudsonΒ SandlerΒ 

Telephone : 020 7796 4133

CHAIRMAN'S STATEMENT

I am pleased to report, once again, a record set of interim results. Whilst the economic backdrop has beenΒ challengingΒ we have charted a successful course in theΒ firstΒ six months of the trading year.

Trading

The first half year trading was very solid with record turnoverΒ of Β£86.65 million (2007: Β£78.45Β million)Β representing an increase of 10.4%Β .Β The majority of the sales growth was derived from our flooring activities though I would note Phoenix Distribution (our motorcycle accessories subsidiary) increased salesΒ byΒ 4% in difficult retail conditions.

Turnover growth was consistent in bothΒ UKΒ and overseas markets, both achieving double digit growth with our international sales continuing to be in excess ofΒ UKΒ sales.

Projects as diverse as Bombadier's Regina Trains in Sweden; the Cooking School in Halifax and the Mozzart Betting Hall in Serbia have continued to broaden ourΒ customer base for products traditionally sold intoΒ our core hospital and education markets.Β We are seeing increasingΒ interest from specifiers and architectsΒ as a result of theΒ high quality of ourΒ designsΒ inΒ highΒ profile installations such as these.

Gross margins improved as raw material and energy costs softened in the second quarter. However,Β this was offset to anΒ extent by the increased cost of factored products and some rawΒ materials and consumables caused byΒ adverse exchange rates. Overall the effect was marginally positive.

The profit before tax at Β£15.37 million (2007: Β£13.08 million) is another record performance and is a 17.5% increase on the comparative period. Finance income has fallen as a result of declines in interest rates. Cash inflow from operations was very positiveΒ increasing byΒ 18.8% to Β£16.82 millionΒ (2007: Β£14.15 million).

Earnings per Share and Interim Dividend

Our basic earnings per share have increased to a record 20.8p (2007 : 17.4p) an uplift of 19.5% and having regard to these results and our strong cash balances the Board propose to pay an interim dividend of 7.25p (2007 : 6.25p) representing a 16% increase on last year and yet another record.

OutlookΒ 

The half year result is encouraging. Looking forward,Β we have range changes and updates taking place in the second half and we continue to focus on productivity. Sterling weaknessΒ will,Β on balance, be a positiveΒ withΒ our export performance more than compensating for higher cost of imported items. In addition,Β we are seeing reduced energy prices and this cost area isΒ being targeted for efficiency improvement. These factors giveΒ usΒ confidence for the coming months. However what cannot be ignored,Β is the general decline in global trade and widespread recessionary worries, which to date weΒ have not experiencedΒ in terms of trading in our market sector,Β except for some smaller territories.

With talk of an economic "PearlΒ Harbour" we mustΒ remain alert toΒ potential problems,Β whether they are deferred spending or credit risks. I am confident we have the management skills, products and reputation toΒ strengthenΒ market share in these difficult timesΒ in key territories.

Β Whilst projects such as the Nevis Alexandra Hospital in Barbados, the Dubai Rugby Seven Stadium and VDL buses for Israel augment our breadth of expansion, there are significant projects such as Manchester and Birmingham schools closer to home that are targeted to underpin our second half budgets. Indeed,Β in the area of healthcare we have even managed to supply flooring to the BBC's "Casualty 1909",Β a new drama series.

The second half will be a hard challenge butΒ we face it fromΒ a position ofΒ strength.

Geoffrey Halstead

Chairman

30 March 2009

Β Β Consolidated Income Statement

for the half-year endedΒ 31 December 2008

Half-yearΒ 

ended

31.12.08

Β£'000

Half-yearΒ 

endedΒ 

31.12.07Β 

Β£'000Β 

YearΒ 

ended

30.06.08

Β£'000

Revenue

86,650

78,453Β 

158,740Β 

Operating profit

15,052

12,579Β 

29,088Β 

Finance income

316

500Β 

769Β 

Profit before income tax

15,368

13,079Β 

29,857Β 

Income tax expense

(4,668)

(4,208)

(9,502)

Profit for the period

10,700

8,871Β 

20,355Β 

Earnings per ordinary share of 5p :

-basic

20.8p

17.4p

39.7p

-diluted

20.7p

17.2p

39.5p

All the above figures relate to continuing operations.

Details of dividends paid and proposed are given in noteΒ 3.

Β Β ConsolidatedΒ Balance Sheet

as atΒ 31 December 2008

Half-year

ended

31.12.08

Β£'000

Half-year

ended

31.12.07

Β£'000

Year

ended

30.06.08

Β£'000

Non current assets

Property, plant and equipment

22,804

19,905

19,671

Intangible assets

3,232

3,232

3,232

Deferred tax assets

5,832

3,850

5,737

31,868

26,987

28,640

Current assets

Inventories

33,121

24,884

30,641

Trade and other receivables

25,835

24,045

23,034

Derivative financial instruments

741

59

149

Cash and cash equivalents

31,764

25,922

29,521

91,461

74,910

83,345

Current liabilities

53,722

50,104

48,631

Net current assets

37,739

24,806

34,714

Non-current liabilities

Retirement benefit obligations

12,227

7,158

12,505

Deferred tax liabilities

992

1,063

992

Other payables

594

662

550

13,813

8,883

14,047

Net Assets

55,794

42,910

49,307

Equity

Equity share capital

2,574

2,556

2,574

Equity share capital (B shares)

160

160

160

2,734

2,716

2,734

Share premium account

1,738

824

1,708

Retained earnings

39,941

34,883

36,455

Other reserves

11,381

4,487

8,410

Total equity attributable to shareholders of the parent

55,794

42,910

49,307

Β Β Consolidated Cash Flow Statement

for the half-year endedΒ 31 December 2008

Half-year

ended

31.12.08

Β£'000

Half-year

ended

31.12.07

Β£'000

Year

ended

30.06.08

Β£'000

Cash inflow from operations

16,818Β 

14,151Β 

27,298Β 

Interest received

606Β 

624Β 

1,261Β 

Interest paid

(94)

(120)

(243)

Taxation paid

(5,410)

(3,428)

(8,081)

Cash inflow from operating activities

11,920Β 

11,227Β 

20,235Β 

Purchase of property, plant and equipment

(3,015)

(2,702)

(3,370)

Proceeds from disposal of property, plant and equipment

73Β 

117Β 

205Β 

Cash outflow from investing activities

(2,942)

(2,585)

(3,165)

Equity dividends paid

(7,465)

(5,751)

(8,946)

Shares issued

30Β 

22Β 

924Β 

Interest paid

(6)

(6)

(117)

Repayment of debt

-Β 

-Β 

(2,653)

Cash outflow from financing activities

(7,441)

(5,735)

(10,792)

Net increase in cash and cash equivalents

1,537Β 

2,907Β 

6,278Β 

Effect of exchange differencesΒ 

706Β 

259Β 

487Β 

Cash and cash equivalents at start of period

29,521Β 

22,756Β 

22,756Β 

Cash and cash equivalents at end of period

31,764Β 

25,922Β 

29,521Β 

Β Β ConsolidatedΒ Statement of Recognised Income and Expense

for the half-year endedΒ 31 December 2008

Half-year

ended

31.12.08

Β£'000Β 

Half-year

ended

31.12.07

Β£'000

Year

ended

30.06.08

Β£'000

Foreign currency translation differences

3,286Β 

827Β 

2,053Β 

Actuarial gain/(loss) on the pension scheme

251Β 

(537)

(4,683)

Fair value movements on hedged items

(315)

(213)

(169)

Net income/(expense) recognised directly in equity

3,222Β 

77Β 

(2,799)

Profit for the year

10,700Β 

8,871Β 

20,355Β 

Total recognised income for the period

13,922Β 

8,948Β 

17,556Β 

Attributable to :

Equity holders of the company

13,922Β 

8,948Β 

17,556Β 

Β Β Notes to the Interim Results

for the half-year endedΒ 31 December 2008

1.

Basis of preparation

The interim financial statements are unaudited and do not constitute statutory accounts as defined within the Companies Act 1985.Β 

The principalΒ accounting policies applied in the preparation of the consolidated interim statements areΒ those set out in the annual report and accounts for the year endedΒ 30 June 2008.

The figures for the year endedΒ 30 June 2008Β are an abridged statement of theΒ Group audited accounts for thatΒ year. The financial statements for the year endedΒ 30 June 2008Β were audited and have been delivered to the Registrar of Companies.

Β 

As is permitted by the AIM rules, the directors have not adopted the requirements of IAS34 'Interim Financial Reporting' in preparing the interimΒ financialΒ statements.Β Accordingly the interim financial statements are not in fullΒ compliance with IFRS.

2.

Income tax has been provided at the rate of 30.4% (2007 : 32.2%).

Β Β 

3.

Dividends

Half-yearΒ 

ended

31.12.08

Β£'000

Half-yearΒ 

ended

31.12.07

Β£'000

YearΒ 

ended

30.06.08

Β£'000

Equity dividends paid :

Final dividend for the year endedΒ 30 June 2007

-

5,751

5,751

Interim dividend for the year endedΒ 30 June 2008

-

-

3,195

Final dividend for the year endedΒ 30 June 2008

7,465

-

-

7,465

5,751

8,946

Equity dividends proposed at the end of the period

Interim dividend

3,732

3,195

-

Final dividend

-

-

7,465

Equity dividends per share, paid and proposed, are as follows :

Β 

11.25p final dividend for the year ended 30 June 2007, paid onΒ 7Β December 2007

6.25p interim dividend for the year ended 30 June 2008, paid on 23 May 2008

14.5p final dividend for the year ended 30 June 2008, paid onΒ 12Β December 2008

7.25p interim dividend for the year ended 30 June 2009, payable on 22Β May 2009Β to those shareholders on the register at the close of business on 22Β April 2009.

Β Β 

4.

Calculation of earnings per ordinary share

Half-yearΒ 

ended

31.12.08

Β£'000

Half-yearΒ 

ended

31.12.07

Β£'000

YearΒ 

ended

30.06.08

Β£'000

Basic earnings

10,700

8,871

20,355

Weighted average number of ordinary shares in issue

51,480,630

51,113,192

51,305,038

Weighted average number of ordinary shares in issue (diluted for the effect of outstanding share options)

51,624,129

51,558,120

51,519,840

Basic earnings per 5p ordinary share

20.8p

17.4p

39.7p

Diluted earnings per 5p ordinary share

20.7p

17.2p

39.5p

5.

Copies of the interim results

Copies of the interim results have been sent to shareholders. Further copies can be obtained from the company's registered office, Beechfield,Β Hollinhurst Road, Radcliffe,Β Manchester,Β M26 1JN.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR SEAFWWSUSEDD
Date   Source Headline
1st Dec 20177:00 amRNSAGM Statement
20th Oct 20173:00 pmRNSAnnual Report & Accounts
2nd Oct 20177:00 amRNSBoard Changes
2nd Oct 20177:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
14th Sep 201712:42 pmRNSNotice of Preliminary Results
14th Sep 20177:00 amRNSNotice of Preliminary Results
1st Aug 201710:43 amRNSTotal Voting Rights
1st Aug 20177:00 amRNSPre-Close Trading Statement
31st Jul 20175:53 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:40 pmRNSTotal Voting Rights
3rd Jul 20175:37 pmRNSBlock listing Interim Review
23rd Jun 20174:12 pmRNSDirector/PDMR Shareholding
12th Jun 201712:54 pmRNSDirector/PDMR Shareholding
9th Jun 20175:37 pmRNSTotal Voting Rights
12th May 20175:29 pmRNSDirector/PDMR Shareholding
12th May 20173:59 pmRNSDirector/PDMR Shareholding
5th Apr 20172:36 pmRNSDirector/PDMR Shareholding
29th Mar 20177:00 amRNSInterim Results
6th Mar 20177:00 amRNSNotice of Results
30th Jan 20177:00 amRNSPre Close Trading Statement
13th Dec 201611:13 amRNSResult of AGM
2nd Dec 20167:00 amRNSAGM Statement
1st Dec 20167:00 amRNSTotal Voting Rights
1st Nov 201612:24 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSAnnual Financial Report
3rd Oct 20167:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
21st Sep 20167:00 amRNSNotice of Preliminary Results
15th Aug 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Aug 20167:00 amRNSPre-Close Trading Statement
1st Jul 20163:41 pmRNSBlock listing Interim Review
31st Mar 20167:00 amRNSInterim Results
8th Mar 20167:00 amRNSNotice of Interim Results
1st Feb 20164:51 pmRNSTotal Voting Rights
1st Feb 20167:00 amRNSPre Close Trading Statement
3rd Dec 20155:20 pmRNSDirector/PDMR Shareholding
1st Dec 20152:45 pmRNSTotal Voting Rights
27th Nov 201512:00 pmRNSChairman's Statement to the Annual General Meeting
2nd Nov 201511:39 amRNSTotal Voting Rights
29th Oct 20154:44 pmRNSDirector/PDMR Shareholding
23rd Oct 20159:45 amRNSAnnual Financial Report & Notice of AGM
29th Sep 20157:00 amRNSFinal Results
18th Sep 20157:00 amRNSNotice of Preliminary Results
31st Jul 20157:00 amRNSTotal Voting Rights
29th Jul 20157:00 amRNSPre-Close Trading Statement
28th Jul 20156:00 pmRNSBlocklisting Interim Review
24th Jul 20155:00 pmRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSChange of Adviser
3rd Jun 20157:00 amRNSTotal Voting Rights
31st Mar 20157:00 amRNSInterim Results
20th Mar 20154:31 pmRNSNotice of Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.